Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

甲基苯丙胺（冰毒）成瘾是一个日益严重的社区问题，与严重的疾病和死亡有关。目前的咨询方法本身的成功有限，需要更有效的药物治疗。利右苯丙胺是一种新获得许可的兴奋剂药物，在治疗这些患者方面有很大的希望。这项试验将研究是否lisdexamfetamine（与辅导）安全地减少甲基苯丙胺的使用，并改善健康和福祉的重度用户。

Addiction to methamphetamines (‘ice’) is a growing community problem linked to serious disease and death. Current counselling approaches have limited success on their own, and more effective treatments linked to medications are needed. Lisdexamfetamine is a newly licenced stimulant medication with great promise in treating these patients. This trial will examine whether lisdexamfetamine (with counselling) safely reduces methamphetamine use and improves health and wellbeing among heavy users.